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Castleman’s disease (CD) was first identified in 1954
as a mass in the mediastinum resembling a thymoma
[1]. CD is a rare, benign lymphoproliferative disorder
of unknown cause. CD may be found in lymph nodes
in any body regions. There are two histologic types 
of CD: the hyaline-vascular type and the plasma cell
type. In the head and neck, 98% of these lesions are 
of the hyaline-vascular type [2]. This type is usually a
localized form without constitutional symptoms, and
has more favorable prognosis than the other subtypes.
CD often represents a diagnostic challenge to the phy-
sician because it presents with nonspecific symptoms
and tends to imitate head and neck neoplasms. A defin-
itive diagnosis of CD is only achieved with histologic
analysis.
CASE PRESENTATION
A 34-year-old woman was admitted to our clinic for
evaluation of an abnormal cranial magnetic resonance
imaging (MRI) finding. Approximately 1 year earlier,
she had undergone surgery for a cerebellar mass. The
abnormal finding was seen in her routine cranial MRI
scan, with a 10×15-mm mass in her left parotid gland
(Figure 1). She denied any constitutional symptoms
except tinnitus in her left ear lasting for 6 months.
Physical examination revealed no mass or swelling
in the left parotid region. The facial nerve functions
were intact. There was no associated lymphadenopa-
thy. Her complete blood count, chemistry profiles and
chest X-ray findings were all within normal limits.
Ultrasonography demonstrated a 14×15-mm mass 
in her left parotid gland with hypoechoic vascularity.
Computed tomography (CT) scans showed a well-
marginated, round, homogenous mass in the posterior
region of the angulus mandible extending into the deep
lobe of the left parotid gland (Figure 2). Ultrasound-
guided fine-needle aspiration was performed and the
Received: Dec 22, 2009 Accepted: Jan 19, 2010
Address correspondence and reprint requests to:
Dr Levent Gürbüzler, Department of Otorhino-
laryngology, School of Medicine, Gaziosmanpas¸a
University, Tokat, Turkey.
E-mail: gurbuzler@yahoo.com
CASTLEMAN’S DISEASE OF THE
PAROTID GLAND: A CASE REPORT
Levent Gürbüzler,1 Alper Ceylan,1 Metin Yılmaz,1 and Çiğdem Vural2
Departments of 1Otorhinolaryngology and 2Pathology, School of Medicine, 
Gaziosmanpas¸a University, Tokat, Turkey.
Castleman’s disease (CD) is a very rare disorder characterized by non-neoplastic growths in lymph
nodes in any body regions, although over 60% of cases are located in the mediastinum. The head
and neck is the second most commonly involved site, with up to 14% of cases. Of these, nearly
85% are located in the neck. These lesions rarely occur in the salivary glands. Clinically, CD can
be divided into unicentric and multicentric forms. We report an unusual case with unicentric CD
presenting as a parotid tumor in a 34-year-old woman. The lesion was found coincidentally during
routine cranial magnetic resonance imaging in the absence of symptoms such as swelling or a
mass in the parotid region.
Key Words: Castleman’s disease, head and neck, parotid gland 
(Kaohsiung J Med Sci 2010;26:444–7)
Castleman’s disease in the parotid gland
Kaohsiung J Med Sci August 2010 • Vol 26 • No 8 445
biopsy was non-diagnostic. The patient underwent a
total parotidectomy with preservation of the facial
nerve. After dissecting the superficial parotid lobe
from the facial nerve, a 15×15×10-mm round, solid
grey mass was found in the deep lobe. The mass was
in the anteroinferior location of the main truncus 
of the facial nerve. There was no adhesion between
the mass and the surrounding gland parenchyme or
facial nerve. The deep lobe containing the mass was
carefully dissected. Histologic analysis of the surgical
specimen showed the CD was of the hyaline-vascular
type, and no further treatment was given (Figure 3).
Postoperatively, the patient made an excellent recov-
ery and continues to be free of disease 8 months after
surgery.
DISCUSSION
CD is an uncommon benign lymphoproliferative dis-
order with unknown etiology. CD has been referred
to by many names, including giant lymph node
hyperplasia, angiomatous lymph node hamartoma,
angiofollicular lymph node hyperplasia, follicular
lymphoreticuloma and benign giant lymphoma [1–6].
This variable terminology reflects its uncertain cause,
although the most tenable theories of pathogenesis are
that CD is derived from hamartomatous or inflamma-
tory processes. CD mainly affects young adults aged
15–35 years old, but shows no sex predilection [6].
The pathogenesis of CD is not well understood.
Some authors have proposed a reactive lymph node
hyperplasia theory in which the disease is an immuno-
logic response whereas other authors have suggested it
is derived from a benign tumor or hamartoma [1,7,8].
CD may occur at any lymph node in the body, al-
though the mediastinum is the most common location
of the disease, accounting for 60% of all occurrences,
followed by the head and neck region accounting for
14% of occurrences [2]. Additional sites of occurrence
include the axilla, retroperitoneum, mesentery, vulva,
pancreas, and pelvis [5]. Within the head and neck,
85% of lesions occur in the neck, while salivary gland
involvement is very rare.
Clinically, there are two forms of CD, unicentric and
multicentric. The unicentric form, as in our case, is the
Figure 1. Magnetic resonance imaging. T2-weighted axial image
showing high signal intensity mass in the parotid gland.
Figure 2. Computed tomography imaging. Intravenous contrast
enhancement shows a well-marginated mass in the posterior part of
the angulus mandible extending to the deep lobe of parotid gland.
Figure 3. Histologic “onion skin” appearance characterized by
concentric layers of small lymphocytes (hematoxylin and eosin;
original magnification, 100×).
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most common form and usually presents in a lym-
phonodular region in the absence of other symptoms
[1,2,9]. The multicentric form is often associated with
fever, diaphoresis, fatigue, weight loss and disorders,
e.g. anemia, hyperglobulinemia, nephrotic syndrome,
elevated erythrocyte sedimentation rate and hepatos-
plenomegaly [9]. This form has also been associated
with some malignancies, e.g. Kaposi’s sarcoma, non-
Hodgkin’s lymphoma, Hodgkin’s disease and POEMS
syndrome (polyneuropathy, organomegaly, endocri-
nopathy, M protein and skin changes) [1,9,10]. It is
also associated with human immunodeficiency virus
and human herpes virus [10,11]. Oral erosive lichen
planus and pemphigus have also been reported to be
associated with multicentric CD [12].
Histologically, there are two different types of CD,
the hyaline-vascular type and the plasma cell type.
The hyaline-vascular type, as in our case, is the most
common type and accounts for 90% of all cases [4]. 
It usually affects a single lymph node. The histologic
appearance of this type includes lymphoid follicles
surrounded by concentric layers of small lymphoid
cells with an “onion skin” appearance. The atrophic
germinal centers are traversed by mantle zone lympho-
cytes. The plasma cell type is a relatively uncommon
type of CD and is associated with systemic symptoms
and abnormal hematologic values. Histologically, the
plasma cell type is characterized by a dense infiltra-
tion of plasma cells and involves several lymph nodes.
However, intermediate forms showing transition be-
tween the two types have been also described [13]. It
has been suggested that the plasma cell type is an
earlier stage of the hyaline-vascular type or that both
types represent different responses of the same process
[1,2,4,6,14].
Although CD may be included in the differential
diagnosis of lymphoproliferative disorders in the head
and neck, CD in the parotid gland poses considerable
diagnostic difficulties owing to its unusual location
and its tendency to mimic neoplasms. In our case,
MRI and CT findings and the patient’s medical history
suggested that the mass was a benign neoplasm.
Tests can occasionally be helpful for differential
diagnosis. CT scans show dense, homogenous en-
hancement after intravenous contrast administration
[2,15]. The hyaline-vascular type tends to show gre-
ater enhancement owing to its hypervascularity [5].
Although MRI features are not specific, CD should be
considered in the differential diagnosis for a solitary
neck mass showing low to intermediate signal inten-
sity on T1-weighted images and high signal intensity
on T2-weighted images [7,15].
The definitive diagnosis of CD is based on his-
tologic analysis [1,2,3,9]. The treatment choice for
unicentric lesions is excision of the mass. If excision 
is complete, recurrence is uncommon. Although
Sanchez-Cuellar et al recommended chemotherapy
for the plasma cell type; most authors suggested surgi-
cal excision [1]. The systemic symptoms usually abate
in 30–60 days. The multicentric form of CD has a poor
prognosis and warrants aggressive therapy. Due to
the multisystem involvement of multicentric CD, treat-
ments may require surgery plus chemotherapy [2].
In conclusion, CD is a benign lymphoproliferative
disease that rarely occurs in the head and neck region.
CD should be included in the differential diagnosis
when considering a lymphoproliferative lesion in the
parotid gland. The hyaline-vascular type is more com-
mon than the plasma cell type. Surgical excision is the
preferred treatment for unicentric CD, whereas the
multicentric form requires more aggressive treatment
and long-term follow up.
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